- JP-listed companies
- Cuorips Inc.
- Ownership
Cuorips Inc. (4894) Shareholders
Market cap
¥37.7B
P/E ratio
-27.1x
Qualips develops regenerative medicine treatments using human iPS cells, specializing in cardiac muscle cell sheets for severe heart failure patients.
大株主
| （単位：千株） | 2023/03 | 2024/03 | 2025/03 | 2026/03 |
|---|---|---|---|---|
| 第一三共 | 1,000 17.67% | 1,000 12.57% | 1,000 12.36% | 1,000 12.11% |
| テルモ | 530 9.36% | 530 6.66% | 530 6.55% | 530 6.42% |
| 澤 芳樹 | 128 2.26% | 186 2.34% | 205.2 2.54% | 123 1.49% |
| 松井証券 | 127.3 1.57% | 111.5 1.35% | ||
| DEFTA LIMITED | 111 1.4% | 111 1.37% | 111 1.34% | |
| 朝日インテック | 100 1.26% | 100 1.24% | 100 1.21% | |
| ダイダン | 100 1.26% | 100 1.24% | 100 1.21% | |
| 楽天証券 | 129.8 1.63% | 89.8 1.09% | ||
| JPモルガン証券 | 88.6 1.07% | |||
| 草薙 尊之 | 61.25 0.74% | |||
| 富士フイルム | 100 1.26% | 100 1.24% | ||
| イノベーション京都2016投資事業有限責任組合 | 580 10.25% | 355.2 4.47% | 88.4 1.09% | |
| 井上 学 | 140.05 1.76% | 82.05 1.01% | ||
| JICベンチャー・グロース・ファンド1号投資事業有限責任組合 | 500 8.83% | 500 6.29% | ||
| 大幸薬品 | 500 8.83% | 100 1.26% | ||
| SBI Ventures Two | 500 8.83% | |||
| ジャフコSV6投資事業有限責任組合 | 400 7.07% | |||
| 三菱商事 | 273.333 4.83% | |||
| 京大ベンチャーNVCC2号投資事業有限責任組合 | 216 3.82% | |||
| 計 | 4,627.333 81.74% | 3,352.05 42.15% | 2,443.95 30.2% | 2,315.15 28.04% |